Search results
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC News via Yahoo News· 15 hours agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks via Yahoo Finance· 3 days agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 1 day agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
This Pharma Stock Is Poised to Keep Outperforming the S&P 500
The Motley Fool via AOL· 2 days agoAstraZeneca has quietly delivered market-beating results since 2014. Despite skepticism, the company...
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock
The Motley Fool via AOL· 3 days agoAs two of the world's largest and most prolific drugmakers, Pfizer (NYSE: PFE) and AstraZeneca...
Why Is AstraZeneca Stock Trading Lower On Tuesday?
Benzinga via AOL· 4 days agoOn Tuesday, AstraZeneca Plc (NASDAQ:AZN) said the survival results did not reach statistical significance in the overall trial population in the...
AstraZeneca (NASDAQ:AZN) Now Covered by Analysts at The Goldman Sachs Group
ETF DAILY NEWS· 1 day agoThe Goldman Sachs Group assumed coverage on shares of AstraZeneca (NASDAQ:AZN – Free Report) in a research report report published on Thursday morning, Marketbeat Ratings ...
AstraZeneca-Daiichi's Enhertu follow-up Dato-DXd unable to prove overall survival benefit in phase 3
FierceBiotech· 4 days agoDaiichi Sankyo and antibody-drug conjugate (ADC) partner AstraZeneca have already filed their...
AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
Motley Fool via Yahoo Finance· 3 days agoAstraZeneca (NASDAQ: AZN) is embarking on a fresh business plan that will see it grow significantly...
AstraZeneca stock upgraded by Goldman, 27% upside seen By Investing.com
Investing.com· 2 days agoOn Thursday, Goldman Sachs (NYSE:GS) initiated coverage on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN)...